Erratum: Marked difference in saxitoxin and tetrodoxin affinity for the human nociceptive voltage-gated sodium channel (Nav 1.7) (Proceedings of the National Academy of Sciences of the United States of America (2012) 109, 44 (18102-18107) DOI: 10.1073/pnas.1206952109);Marked difference in saxitoxin and tetrodoxin affinity for the human nociceptive voltage-gated sodium channel (Nav1.7)

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 44, 2012, Pages 18102-18107

  Walker, James R ^a   Novick, Paul A ^a   Parsons, William H ^a   McGregor, Malcolm ^b   Zablocki, Jeff ^c   Pande, Vijay S ^a,d,e   Du Bois, J ^a  

^a Department of Chemistry ^*  (United States)

^b ACCELRYS INC   (United States)

^c GILEAD SCIENCES   (United States)

^d STANFORD UNIVERSITY   (United States)

^e Stanford University   (United States)

Author keywords

Guanidinium toxin; SCN9A

Indexed keywords

AMINO ACID; GONYAUTOXIN; ISOLEUCINE; SAXITOXIN; SODIUM CHANNEL NAV1.7; TETRODOTOXIN; THREONINE;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; BINDING SITE; CONTROLLED STUDY; ELECTROPHYSIOLOGY; LIGAND BINDING; MOLECULAR INTERACTION; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; SEQUENCE ALIGNMENT;

EID: 84868151817     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1220041110     Document Type: Erratum

References (47)

1. Catterall WA, Goldin AL, Waxman SG; International Union of Pharmacology (2003) International Union of Pharmacology. XXXIX. Compendium of voltage-gated ion channels: Sodium channels. Pharmacol Rev 55(4):575-578.
2. Novella SP, Hisama FM, Dib-Hajj SD, Waxman SG (2007) A case of inherited erythromelalgia. Nat Clin Pract Neurol 3(4):229-234.
3. Cox JJ, et al. (2006) An SCN9A channelopathy causes congenital inability to experience pain. Nature 444(7121):894-898.
4. Williams BS, et al. (2007) Characterization of a new class of potent inhibitors of the voltage-gated sodium channel Nav1.7. Biochemistry 46(50):14693-14703.
5. Schmalhofer WA, et al. (2008) ProTx-II, a selective inhibitor of NaV1.7 sodium channels, blocks action potential propagation in nociceptors. Mol Pharmacol 74(5): 1476-1484.
6. Young FB (2008) A life without pain? Hedonists take note. Clin Genet 73(1):31-33.
7. Lampert A, O'Reilly AO, Reeh P, Leffler A (2010) Sodium channelopathies and pain. Pflugers Arch 460(2):249-263.
8. Payandeh J, Scheuer T, Zheng N, Catterall WA (2011) The crystal structure of a voltage- gated sodium channel. Nature 475(7356):353-358.
9. Zhang X, et al. (2012) Crystal structure of an orthologue of the NaChBac voltagegated sodium channel. Nature 486(7401):130-134.
10. Fozzard HA, Lipkind GM (2010) The tetrodotoxin binding site is within the outer vestibule of the sodium channel. Mar Drugs 8(2):219-234.
11. Schantz EJ, et al. (1975) Letter: The structure of saxitoxin. J Am Chem Soc 97(5): 1238-1239.
12. Llewellyn LE (2006) Saxitoxin, a toxic marine natural product that targets a multitude of receptors. Nat Prod Rep 23(2):200-222.
13. Strichartz G (1984) Structural determinants of the affinity of saxitoxin for neuronal sodium channels. Electrophysiological studies on frog peripheral nerve. J Gen Physiol 84(2):281-305.
14. Rosker C, et al. (2007) The TTX metabolite 4,9-anhydro-TTX is a highly specific blocker of the Na(v1.6) voltage-dependent sodium channel. Am J Physiol Cell Physiol 293(2): C783-C789.
15. McGowan E, Hoyt SB, Li X, Lyons KA, Abbadie C (2009) A peripherally acting Na(v)1.7 sodium channel blocker reverses hyperalgesia and allodynia on rat models of inflammatory and neuropathic pain. Anesth Analg 109(3):951-958.
16. Rodríguez-Navarro AJ, et al. (2011) Comparison of neosaxitoxin versus bupivacaine via port infiltration for postoperative analgesia following laparoscopic cholecystectomy: A randomized, double-blind trial. Reg Anesth Pain Med 36(2):103-109.
17. Nieto FR, et al. (2012) Tetrodotoxin (TTX) as a therapeutic agent for pain. Mar Drugs 10(2):281-305.
18. Garrido R, et al. (2007) Treatment of chronic anal fissure by gonyautoxin. Colorectal Dis 9(7):619-624.
19. Garrido R, et al. (2005) Gonyautoxin: New treatment for healing acute and chronic anal fissures. Dis Colon Rectum 48(2):335-340.
20. Garrido R, et al. (2004) The gonyautoxin 2/3 epimers reduces anal tone when injected in the anal sphincter of healthy adults. Biol Res 37(3):395-403.
21. Lattes K, et al. (2009) Local infiltration of gonyautoxin is safe and effective in treatment of chronic tension-type headache. Neurol Res 31(3):228-233.
22. Rodriguez-Navarro AJ, et al. (2009) Potentiation of local anesthetic activity of neosaxitoxin with bupivacaine or epinephrine: Development of a long-acting pain blocker. Neurotox Res 16(4):408-415.
23. Rodriguez-Navarro AJ, et al. (2007) Neosaxitoxin as a local anesthetic: Preliminary observations from a first human trial. Anesthesiology 106(2):339-345.
24. Jost MC, et al. (2008) Toxin-resistant sodium channels: Parallel adaptive evolution across a complete gene family. Mol Biol Evol 25(6):1016-1024.
25. Tikhonov DB, Zhorov BS (2005) Modeling P-loops domain of sodium channel: Homology with potassium channels and interaction with ligands. Biophys J 88(1):184-197.
26. Lipkind GM, Fozzard HA (2000) KcsA crystal structure as framework for a molecular model of the Na(+) channel pore. Biochemistry 39(28):8161-8170.
27. Penzotti JL, Fozzard HA, Lipkind GM, Dudley SC, Jr. (1998) Differences in saxitoxin and tetrodotoxin binding revealed by mutagenesis of the Na+ channel outer vestibule. Biophys J 75(6):2647-2657.
28. Santarelli VP, Eastwood AL, Dougherty DA, Horn R, Ahern CA (2007) A cation-pi interaction discriminates among sodium channels that are either sensitive or resistant to tetrodotoxin block. J Biol Chem 282(11):8044-8051.
29. Scheib H, et al. (2006) Modeling the pore structure of voltage-gated sodium channels in closed, open, and fast-inactivated conformation reveals details of site 1 toxin and local anesthetic binding. J Mol Model 12(6):813-822.
30. Tikhonov DB, Zhorov BS (2012) Architecture and pore block of eukaryotic voltagegated sodium channels in view of NavAb bacterial sodium channel structure. Mol Pharmacol 82(1):97-104.
31. Ren D, et al. (2001) A prokaryotic voltage-gated sodium channel. Science 294(5550): 2372-2375.
32. Sivilotti L, Okuse K, Akopian AN, Moss S, Wood JN (1997) A single serine residue confers tetrodotoxin insensitivity on the rat sensory-neuron-specific sodium channel SNS. FEBS Lett 409(1):49-52.
33. Satin J, et al. (1992) A mutant of TTX-resistant cardiac sodium channels with TTXsensitive properties. Science 256(5060):1202-1205.
34. Leffler A, Herzog RI, Dib-Hajj SD, Waxman SG, Cummins TR (2005) Pharmacological properties of neuronal TTX-resistant sodium channels and the role of a critical serine pore residue. Pflugers Arch 451(3):454-463.
35. Geffeney SL, Fujimoto E, Brodie ED, 3rd, Brodie ED, Jr., Ruben PC (2005) Evolutionary diversification of TTX-resistant sodium channels in a predator-prey interaction. Nature 434(7034):759-763.
36. Bricelj VM, et al. (2005) Sodium channel mutation leading to saxitoxin resistance in clams increases risk of PSP. Nature 434(7034):763-767.
37. Terlau H, et al. (1991) Mapping the site of block by tetrodotoxin and saxitoxin of sodium channel II. FEBS Lett 293(1-2):93-96.
38. Belcher SM, Zerillo CA, Levenson R, Ritchie JM, Howe JR (1995) Cloning of a sodium channel alpha subunit from rabbit Schwann cells. Proc Natl Acad Sci USA 92(24):11034-11038.
39. Wada A, Yanagita T, Yokoo H, Kobayashi H (2004) Regulation of cell surface expression of voltage-dependent Nav1.7 sodium channels: mRNA stability and posttranscriptional control in adrenal chromaffin cells. Front Biosci 9:1954-1966.
40. Rudy B, Kirschenbaum B, Greene LA (1982) Nerve growth factor-induced increase in saxitoxin binding to rat PC12 pheochromocytoma cells. J Neurosci 2(10):1405-1411.
41. Klugbauer N, Lacinova L, Flockerzi V, Hofmann F (1995) Structure and functional expression of a new member of the tetrodotoxin-sensitive voltage-activated sodium channel family from human neuroendocrine cells. EMBO J 14(6):1084-1090.
42. Bennett E, Urcan MS, Tinkle SS, Koszowski AG, Levinson SR (1997) Contribution of sialic acid to the voltage dependence of sodium channel gating. A possible electrostatic mechanism. J Gen Physiol 109(3):327-343.
43. Moran O, Picollo A, Conti F (2003) Tonic and phasic guanidinium toxin-block of skeletal muscle Na channels expressed in Mammalian cells. Biophys J 84(5): 2999-3006.
44. Mulcahy JV, Du Bois J (2008) A stereoselective synthesis of (+)-gonyautoxin 3. J Am Chem Soc 130(38):12630-12631.
45. Fleming JJ, McReynolds MD, Du Bois J (2007) (+)-Saxitoxin: A first and second generation stereoselective synthesis. J Am Chem Soc 129(32):9964-9975.
46. Sali A, Blundell TL (1993) Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol 234(3):779-815.
47. Baker NA, Sept D, Joseph S, Holst MJ, McCammon JA (2001) Electrostatics of nanosystems: Application to microtubules and the ribosome. Proc Natl Acad Sci USA 98(18): 10037-10041.